---
title: "Accelerated Whole-Body DWI with Deep Learning Reconstruction in Metastatic Prostate Cancer: Image"
id: "medrxiv-11-evaluation-of-accelerated-whole-body-diffusion-weighted-imaging-with-deep"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-11-evaluation-of-accelerated-whole-body-diffusion-weighted-imaging-with-deep"
content_type: "clinical_feed_article"
specialty: "Radiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.17.26362983v1?rss=1"
published_at: "2026-09-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Accelerated Whole-Body DWI with Deep Learning Reconstruction in Metastatic Prostate Cancer: Image
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-11-evaluation-of-accelerated-whole-body-diffusion-weighted-imaging-with-deep
- **Specialty:** [Radiology](https://medichelpline.com/clinical-feed/radiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.17.26362983v1?rss=1)
- **Published At:** 2026-09-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This single-centre prospective preprint assessed an accelerated whole-body diffusion-weighted MRI (WB-DWI) protocol reconstructed with a research variational-network **deep learning** (DL) package in patients with metastatic prostate cancer. - The DL WB-DWI acquisition reduced the number of signal averages and used higher parallel imaging acceleration, producing a 37% reduction in acquisition time compared with standard WB-DWI. - The study enrolled two cohorts at 1.5T: Cohort 1 (n = 10) for blinded qualitative image-quality scoring across four anatomical stations by two radiologists using a 4-point Likert scale; Cohort 2 (n = 20) for quantitative comparison of apparent diffusion coefficient (**ADC**) measurements in hypercellular focal bone metastases. - Radiologists rated both standard and accelerated DL WB-DWI protocols as good-to-excellent across all assessed image-quality metrics; no degradation in perceived image quality was reported for the accelerated DL protocol. - Median lesion **ADC** values and interquartile ranges showed no significant difference between the standard and accelerated DL WB-DWI protocols; agreement was evaluated with Bland–Altman analysis. - The authors conclude that DL-based reconstruction enables faster WB-DWI acquisition without compromising image quality or lesion ADC quantification, supporting potential clinical implementation for staging and therapy assessment in metastatic prostate cancer. - Ethical approval was provided by a national research ethics committee (London - Central Research Ethics Committee, REC reference 21/LO/0079) and the trial is registered (NCT05118555). - Funding sources include NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research, Royal Marsden Cancer Charity, Prostate Cancer UK and CRUK NCITA. - Data from the study are available from the authors on reasonable request. - This work is a preprint and has not undergone peer review; the authors note it should not yet be used to guide clinical practice.
## Clinical Analysis & Structured Key Points
Evaluation of accelerated whole-body diffusion weighted imaging with deep learning reconstruction in patients with metastatic prostate cancer: assessment of image quality and ADC estimates. | medRxiv Skip to main content Evaluation of accelerated whole-body diffusion weighted imaging with deep learning reconstruction in patients with metastatic prostate cancer: assessment of image quality and ADC estimates. Evanthia Kousi , Mihaela Rata , Dow-Mu Koh , Christina Messiou , Nina Tunariu , Georgina Hopkinson , Emily Evans , Omar Darwish , Elisabeth Weiland , Jessica Winfield doi: https://doi.org/10.64898/2026.09.17.26362983 Evanthia Kousi 1 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: evanthia.kousi{at}rmh.nhs.uk Mihaela Rata 1 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Dow-Mu Koh 1 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christina Messiou 1 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nina Tunariu 1 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Georgina Hopkinson 2 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emily Evans 2 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Omar Darwish 3 Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany. Find this author on Google Scholar Find this author on PubMed Search for this author on this site Elisabeth Weiland 3 Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany. Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jessica Winfield 1 MRI Unit, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Objectives: To evaluate the impact of an accelerated whole-body diffusion-weighted MRI (WB-DWI) protocol using deep learning (DL) reconstruction on image quality and apparent diffusion coefficient (ADC) quantification in patients with metastatic prostate cancer. Methods: This single-centre prospective study involved two patient cohorts undergoing standard-of-care WB-MRI at 1.5T. The DL WB-DWI acquisition used fewer signal averages and higher parallel imaging acceleration, reconstructed with a research application DL package based on a variational network. In Cohort 1 (n = 10), qualitative assessment of image quality was performed across four anatomical stations using a 4-point Likert scale by two radiologists, blinded to the DWI protocol. In Cohort 2 (n = 20), ADC values were evaluated in hypercellular focal bone metastases (as determined by a radiologist) and compared between the standard and accelerated DL WB-DWI protocols. Image quality scores were analysed using Wilcoxon signed-rank tests (Bonferroni-corrected), and ADC agreement was evaluated via Bland-Altman analysis. Results: Accelerated DL WB-DWI reduced WB-DWI acquisition time by 37% without compromising image quality. Radiologists consistently rated both protocols as good-to-excellent across all image quality metrics. Median ADC estimates in lesions showed no significant difference between protocols; interquartile range of ADC estimates also showed no significant difference. Conclusions: Accelerated DL WB-DWI enables 37% scan time reduction without degrading image quality or affecting ADC estimates of lesions in patients with metastatic prostate cancer. Advances in knowledge: DL-based reconstruction enables faster WB-DWI acquisition without compromising image quality or ADC quantification, supporting clinical implementation in metastatic prostate cancer staging and therapy assessment. Competing Interest Statement The authors have declared no competing interest. Clinical Trial NCT05118555 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: A national research ethics committee (London - Central Research Ethics Committee. REC reference 21/LO/0079; NCT05118555 , clinicaltrials.gov) gave ethical approval of this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Funder Information Declared This study represents independent research funded by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, and by the Royal Marsden Cancer Charity, Prostate Cancer UK and Cancer Research UK (CRUK) National Cancer Imaging Trials Accelerator (NCITA). Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 21, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Evaluation of accelerated whole-body diffusion weighted imaging with deep learning reconstruction in patients with metastatic prostate cancer: assessment of image quality and ADC estimates. Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Evaluation of accelerated whole-body diffusion weighted imaging with deep learning reconstruction in patients with metastatic prostate cancer: assessment of image quality and ADC estimates. Evanthia Kousi , Mihaela Rata , Dow-Mu Koh , Christina Messiou , Nina Tunariu , Georgina Hopkinson , Emily Evans , Omar Darwish , Elisabeth Weiland , Jessica Winfield medRxiv 2026.09.17.26362983; doi: https://doi.org/10.64898/2026.09.17.26362983 Share This Article: Copy Citation Tools Evaluation of accelerated whole-body diffusion weighted imaging with deep learning reconstruction in patients with metastatic prostate cancer: assessment of image quality and ADC estimates. Evanthia Kousi , Mihaela Rata , Dow-Mu Koh , Christina Messiou , Nina Tunariu , Georgina Hopkinson , Emily Evans , Omar Darwish , Elisabeth Weiland , Jessica Winfield medRxiv 2026.09.17.26362983; doi: https://doi.org/10.64898/2026.09.17.26362983 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (335) Cardiovascular Medicine (4832) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15980) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7067) Geriatric Medicine (734) Health Economics (1067) Health Informatics (5061) Health Policy (1438) Health Systems and Quality Improvement (1776) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16310) Intensive Care and Critical Care Medicine (1176) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7294) Nursing (369) Nutrition (1084) Obstetrics and Gynecology (1244) Occupational and Environmental Health (1006) Oncology (3617) Ophthalmology (1055) Orthopedics (398) Otolaryngology (458) Pain Medicine (474) Palliative Medicine (140) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (769) Psychiatry and Clinical Psychology (5921) Public and Global Health (9772) Radiology and Imaging (2433) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (643) Sexual and Reproductive Health (773) Sports Medicine (581) Surgery (783) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [RG-SSL-LOC: Report-Guided Semi-Supervised Model Improves Prostate Cancer Detection on Biparametric](https://medichelpline.com/clinical-feed/medrxiv-3-report-guided-semi-supervised-learning-for-scalable-prostate-cancer-detection.md)
- [Predictors and Trends of One-Day Discharge After Radical Prostatectomy in SEER-Medicare Patients](https://medichelpline.com/clinical-feed/medrxiv-23-geographic-and-clinical-predictors-of-one-day-discharge-after-radical.md)
- [Hormonal Management in Older Transgender and Gender Diverse Adults: Case-Based Considerations](https://medichelpline.com/clinical-feed/pubmed-42274359.md) (DOI: 10.1210/clinem/dgag231)
- [Healthy lifestyle and pan-cancer risk: UK Biobank prospective analysis](https://medichelpline.com/clinical-feed/british-journal-of-cancer-2-healthy-lifestyle-and-cancer-risk-a-pan-cancer-analysis-in-the-uk-biobank.md)
- [Adjusting unmet need for contraception by including husband’s virility in the Revised algorithm](https://medichelpline.com/clinical-feed/plos-one-2-incorporating-husband-s-influence-in-estimating-unmet-need-for-contraception.md)

## Navigation
- [← Back to Radiology Feed](https://medichelpline.com/clinical-feed/radiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.